Physician profile
Timothy Patrick Cobb
NPI 1174781892
$1,259.29
in general payments reported to CMS, 2019-2025
14 companies · $458 in 2025
The $458 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.51 · 2022: $18.96 · 2023: $326 · 2024: $421 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Education: $17.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.16 |
| Education | $17.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $402.23 | 2023-2025 | Farxiga, Airsupra, Andexxa |
| Abbvie INC. | $241.86 | 2022-2025 | Dalvance, Creon, Viberzi |
| Lilly USA, LLC | $104.31 | 2023-2025 | Zepbound, Mounjaro, Emgality |
| Novo Nordisk INC | $91.62 | 2023-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $55.40 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $52.65 | 2025 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $49.23 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $45.32 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $40.75 | 2023-2024 | Xarelto |
| Ani Pharmaceuticals, INC. | $38.05 | 2025 | Purified Cortrophin Gel |
| Ars Pharmaceuticals Operations, INC. | $36.47 | 2025 | Neffy |
| Medtronic, INC. | $36.38 | 2023 | Clydesdale Ptc Spinal System |
| Allergan, INC. | $35.51 | 2019 | |
| Csl Behring | $29.51 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.